St. Clair, E. William http://orcid.org/0000-0003-1181-0650
Baer, Alan N.
Ng, Wan-Fai
Noaiseh, Ghaith
Baldini, Chiara
Tarrant, Teresa K.
Papas, Athena
Devauchelle-Pensec, Valerie
Wang, Liangwei
Xu, Wenjing
Pham, Tuyet-Hang
Sikora, Keith
Rees, William A.
Alevizos, Ilias
Article History
Received: 21 December 2023
Accepted: 18 April 2024
First Online: 5 June 2024
Competing interests
: E.W.S. has consulted for Horizon Therapeutics, Bristol Myers Squibb, Related Sciences, ModernaTx Inc., CSL Behring, Resolve Therapeutics, Zenus Pharmaceuticals/Everest Clinical Research Corporation, Scleroderma Research Foundation/Medpace and Sonoma Biotherapeutics; and receives royalties from UpToDate. A.N.B. has consulted for Bristol Myers Squibb and iCell Gene Therapeutics. W.-F.N. has undertaken clinical trials and provided consultancy or expert advice in the area of Sjögren’s syndrome to the following companies: GlaxoSmithKline, MedImmune, UCB, Abbvie, Roche, Eli Lilly, Takeda, Resolves Therapeutics, Sanofi, Novartis and BMS. G.N. has undertaken clinical trials in the area of Sjögren’s syndrome to the following companies: MedImmune, Horizon, Roche, BMS, Janssen and Novartis; and has provided consultancy or expert advice to Novartis and Janssen. C.B. has undertaken clinical trials and provided consultancy or expert advice in the area of Sjögren’s syndrome to the following companies: GlaxoSmithKline, UCB, Sanofi, Novartis, Aurinia and Horizon. T.K.T. has grant support from Chiesi USA, Horizon Therapeutics, Amgen and X4 Pharmaceuticals; and has provided consultancy for X4 Pharmaceuticals and Chiesi. A.P. has provided consultancy or expert advice in the area of Sjögren’s syndrome to Novartis. V.D.-P. has undertaken clinical trials and provided consultancy or expert advice in the area of Sjögren’s syndrome to the following companies: UCB, Sanofi, Novartis, BMS and Horizon. L.W., W.X., T.-H.P., K.S., W.A.R. and I.A. are employees of Amgen Inc. (formerly Horizon Therapeutics) and own stock.